findmyKOL

Loryn Feinberg, MD

Basic profile

Beth Israel Deaconess Medical Center

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Loryn Feinberg is a Cardiology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 17 publications with 212 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
17publications

Distinct works indexed by OpenAlex, matched via ORCID.

212citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Bidmc / Cardiovascular Div.
330 Brookine Avenue, E, Rw-433
Boston, MA 02215

Telephone

617-667-2737

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86.9%
    Statin24.6%
    Atorvastatin Calcium47%Rosuvastatin Calcium41%Simvastatin7%Pravastatin Sodium5%
    Part D<11 patients
    Beta blocker14.1%
    Metoprolol Succinate65%Carvedilol23%Carvedilol Er12%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    7.2%
    Factor Xa inhibitor6.3%
    Eliquis87%Xarelto13%
    Part D<11 patients
    Phosphodiesterase 3 Inhibitor1%
    Cilostazol100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    5.9%
    SGLT2 inhibitor4.3%
    Jardiance63%Farxiga38%
    Part D<11 patients
    GLP-1 receptor agonist1.6%
    Ozempic100%
    Part D<11 patients
Where care is delivered (Part B)99.3% facility · 0.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”